$AREN
Arena Group Holdings, Inc.

2015 Q2 Form 10-Q Financial Statement

#000114420415049241 Filed on August 14, 2015

View on sec.gov

Income Statement

Concept 2015 Q2 2014 Q4 2014 Q2
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $60.00K $50.00K $70.00K
YoY Change -14.29% -16.67% 16.67%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $60.00K $50.00K $70.00K
YoY Change -14.29% -16.67% 16.67%
Operating Profit -$56.35K -$69.03K
YoY Change -18.37% 18.54%
Interest Expense $10.00K $0.00 $0.00
YoY Change -100.0% -100.0%
% of Operating Profit
Other Income/Expense, Net $6.000K -$1.785K
YoY Change -436.13% -102.19%
Pretax Income -$50.35K -$50.00K -$70.81K
YoY Change -28.9% 0.0% -402.49%
Income Tax $800.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$51.15K -$50.00K -$70.81K
YoY Change -27.77% 0.0% -402.49%
Net Earnings / Revenue
Basic Earnings Per Share -$0.01 -$0.01
Diluted Earnings Per Share -$0.01 -$0.11 -$0.01
COMMON SHARES
Basic Shares Outstanding 9.104M shares 8.958M shares 8.782M shares
Diluted Shares Outstanding 9.104M shares 8.782M shares

Balance Sheet

Concept 2015 Q2 2014 Q4 2014 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $2.400M $2.500M $2.600M
YoY Change -7.69% -3.85% -3.7%
Cash & Equivalents $209.8K $542.2K $420.0K
Short-Term Investments $2.200M $1.900M $2.100M
Other Short-Term Assets $16.95K $29.25K $0.00
YoY Change -8.76%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $2.408M $2.504M $2.600M
YoY Change -7.4% -5.8% -3.7%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00 $0.00 $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $2.408M $2.504M $2.600M
Total Long-Term Assets $0.00 $0.00 $0.00
Total Assets $2.408M $2.504M $2.600M
YoY Change -7.4% -5.8% -3.7%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $9.000K $18.00K $0.00
YoY Change -0.01%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $80.32K $88.79K $100.0K
YoY Change -19.68% -5.78% 0.0%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $80.32K $88.79K $100.0K
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $100.0K $100.0K $100.0K
YoY Change 0.0% 0.0% 0.0%
SHAREHOLDERS EQUITY
Retained Earnings -$62.44M -$62.33M
YoY Change 0.38%
Common Stock $91.16K $89.50K
YoY Change 3.46%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $2.159M $2.247M $2.500M
YoY Change
Total Liabilities & Shareholders Equity $2.408M $2.504M $2.600M
YoY Change -7.4% -5.8% -4.56%

Cashflow Statement

Concept 2015 Q2 2014 Q4 2014 Q2
OPERATING ACTIVITIES
Net Income -$51.15K -$50.00K -$70.81K
YoY Change -27.77% 0.0% -402.49%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$60.00K -$10.00K -$60.00K
YoY Change 0.0% -66.67% 100.0%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities -$500.0K -$30.00K $380.0K
YoY Change -231.58% -150.0% -392.31%
Cash From Investing Activities -$500.0K -$30.00K $380.0K
YoY Change -231.58% -150.0% -392.31%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities -60.00K -10.00K -60.00K
Cash From Investing Activities -500.0K -30.00K 380.0K
Cash From Financing Activities
Net Change In Cash -560.0K -40.00K 320.0K
YoY Change -275.0% -233.33% -300.0%
FREE CASH FLOW
Cash From Operating Activities -$60.00K -$10.00K -$60.00K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2015Q2 issm Common Stock Value To Be Issued
CommonStockValueToBeIssued
12500 USD
CY2014Q4 issm Common Stock Value To Be Issued
CommonStockValueToBeIssued
12500 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-1175 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
22830 USD
CY2014Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2504261 USD
CY2015Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
56349 USD
CY2014Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
69026 USD
CY2015Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-56349 USD
CY2014Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-69026 USD
CY2015Q2 us-gaap Investment Income Net
InvestmentIncomeNet
7011 USD
CY2014Q2 us-gaap Investment Income Net
InvestmentIncomeNet
722 USD
CY2015Q2 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
-2599 USD
CY2014Q2 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
1279 USD
CY2015Q2 us-gaap Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
1588 USD
CY2014Q2 us-gaap Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
-3786 USD
CY2015Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
6000 USD
CY2014Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1785 USD
CY2015Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-50349 USD
CY2014Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
168496 USD
CY2015Q2 us-gaap Other Assets Current
OtherAssetsCurrent
16945 USD
CY2015Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
209767 USD
CY2014Q4 us-gaap Other Assets Current
OtherAssetsCurrent
29245 USD
CY2015Q2 us-gaap Assets Current
AssetsCurrent
2407694 USD
CY2014Q4 us-gaap Assets Current
AssetsCurrent
2504261 USD
CY2015Q2 us-gaap Assets
Assets
2407694 USD
CY2014Q4 us-gaap Assets
Assets
2504261 USD
CY2015Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
9000 USD
CY2014Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
18000 USD
CY2015Q2 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
71324 USD
CY2014Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
70786 USD
CY2015Q2 us-gaap Liabilities Current
LiabilitiesCurrent
80324 USD
CY2014Q4 us-gaap Liabilities Current
LiabilitiesCurrent
88786 USD
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
542215 USD
CY2015Q2 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
168496 USD
CY2015Q2 us-gaap Common Stock Value
CommonStockValue
91163 USD
CY2015Q2 us-gaap Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
2180982 USD
CY2014Q4 us-gaap Common Stock Value
CommonStockValue
89496 USD
CY2014Q4 us-gaap Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
1932801 USD
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8751470 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9065208 shares
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-113105 USD
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-109897 USD
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.02
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.02
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9065208 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
8751470 shares
us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
-11888 USD
us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
1605 USD
CY2015Q2 us-gaap Stockholders Equity
StockholdersEquity
2158874 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-142935 USD
us-gaap Net Income Loss
NetIncomeLoss
-132727 USD
CY2014Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-62330316 USD
CY2014Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
7789 USD
CY2015Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
6614 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
10942 USD
CY2014Q4 us-gaap Stockholders Equity
StockholdersEquity
2246979 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
130054 USD
us-gaap Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
1517 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
11008 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-131927 USD
CY2015Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
64490843 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
800 USD
CY2014Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
64467510 USD
us-gaap Net Income Loss
NetIncomeLoss
-111930 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
430 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
800 USD
CY2015Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-62442246 USD
CY2015Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2407694 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-130054 USD
us-gaap Investment Income Net
InvestmentIncomeNet
11381 USD
us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
-538 USD
us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
11515 USD
us-gaap Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
-11888 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
142935 USD
us-gaap Investment Income Net
InvestmentIncomeNet
17945 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
18924 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-111130 USD
us-gaap Share Based Compensation
ShareBasedCompensation
25000 USD
CY2014Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-70811 USD
CY2015Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
800 USD
CY2014Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2015Q2 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000 USD
CY2015Q2 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
173000 USD
CY2015Q2 us-gaap Asset Backed Securities At Carrying Value
AssetBackedSecuritiesAtCarryingValue
250000 USD
us-gaap Incremental Common Shares Attributable To Conversion Of Preferred Stock
IncrementalCommonSharesAttributableToConversionOfPreferredStock
1321537 shares
CY2015Q2 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
667289 USD
CY2015Q1 issm Stock Issued During Period Per Share Value Of New Issues
StockIssuedDuringPeriodPerShareValueOfNewIssues
0.15
CY2015Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
12500 USD
CY2015Q1 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
83334 shares
CY2015Q2 us-gaap Net Income Loss
NetIncomeLoss
-51149 USD
CY2014Q2 us-gaap Net Income Loss
NetIncomeLoss
-70811 USD
CY2015Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-351 USD
CY2014Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
9229 USD
CY2015Q2 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-53177 USD
CY2014Q2 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-57796 USD
CY2015Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2014Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2015Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
CY2014Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
CY2015Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9104408 shares
CY2014Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8781872 shares
CY2015Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9104408 shares
CY2014Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
8781872 shares
CY2015Q2 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
1677 USD
CY2014Q2 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
-3786 USD
CY2015Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-2028 USD
CY2014Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
13015 USD
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
12500 USD
issm Stock To Be Issued During Period Value Common Stock
StockToBeIssuedDuringPeriodValueCommonStock
12500 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-113105 USD
CY2015Q2 issm Checking Account
CheckingAccount
37000 USD
CY2015Q2 issm Available For Sale Securities Debt Maturities After One Through Three Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsAmortizedCost
1159142 USD
CY2015Q2 issm Available For Sale Securities Debt Maturities After Three Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterThreeYearsAmortizedCost
347937 USD
CY2015Q2 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
663362 USD
CY2015Q2 issm Available For Sale Securities Debt Maturities After One Through Three Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue
1170996 USD
CY2015Q2 issm Available For Sale Securities Debt Maturities After Three Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterThreeYearsFairValue
346624 USD
CY2015Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2014Q4 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
83334 shares
CY2014Q4 issm Stock Issued During Period Per Share Value Of New Issues
StockIssuedDuringPeriodPerShareValueOfNewIssues
0.15
us-gaap Share Based Compensation
ShareBasedCompensation
40418 USD
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-12299 USD
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-16538 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-9000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
0 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-84610 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-75398 USD
us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
1067592 USD
us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
197226 USD
us-gaap Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
0 USD
us-gaap Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
102892 USD
us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
819754 USD
us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
490000 USD
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-247838 USD
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
395666 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-332448 USD
CY2014Q4 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
1925012 USD
CY2014 us-gaap Available For Sale Securities Gross Unrealized Gains
AvailableForSaleSecuritiesGrossUnrealizedGains
23733 USD
CY2014 us-gaap Available For Sale Securities Gross Unrealized Loss
AvailableForSaleSecuritiesGrossUnrealizedLoss
15944 USD
CY2014Q4 us-gaap Available For Sale Securities
AvailableForSaleSecurities
1932801 USD
CY2015Q2 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
2174368 USD
CY2015Q2 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
2174368 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
320268 USD
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
99716 USD
CY2014Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
419984 USD
issm Supplemental Gains Losses Unrealized Securities Net Of Taxes
SupplementalGainsLossesUnrealizedSecuritiesNetOfTaxes
-1175 USD
issm Supplemental Gains Losses Unrealized Securities Net Of Taxes
SupplementalGainsLossesUnrealizedSecuritiesNetOfTaxes
22830 USD
CY2015Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2014Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2015Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2014Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2014Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2015Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
9116313 shares
CY2014Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
8949645 shares
CY2014Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
8949645 shares
CY2015Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
9116313 shares
CY2015Q2 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
83334 shares
CY2015Q2 issm Stock Issued During Period Per Share Value Of New Issues
StockIssuedDuringPeriodPerShareValueOfNewIssues
0.15
CY2015Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
us-gaap Nature Of Operations
NatureOfOperations
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <b><font style="FONT-SIZE: 10pt">1. Organization and Operations</font></b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">Integrated Surgical Systems, Inc. (the &#8220;Company&#8221;) was incorporated in Delaware in 1990 to design, manufacture, sell and service image-directed, computer-controlled robotic software and hardware products for use in orthopedic surgical procedures.&#160;&#160;On June 28, 2007, the Company completed the sale of substantially all of its operating assets.&#160;&#160;After completion of the sale, the Company no longer engaged in any business activities related to its former business described above. The Company&#8217;s current operations are limited to completing a business combination or strategic alliance, when a suitable candidate is identified.</font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
us-gaap Use Of Estimates
UseOfEstimates
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><i><font style="FONT-SIZE: 10pt">Use of Estimates</font></i></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and revenues and expenses for the reporting period.&#160;&#160;Actual results could differ from those estimates.</font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
0.17
us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
P3Y5M16D
CY2015Q2 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
200000 shares
CY2015Q2 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
0.17
CY2015Q2 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
200000 shares
CY2015Q2 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
0.17
us-gaap Available For Sale Securities Gross Unrealized Gains
AvailableForSaleSecuritiesGrossUnrealizedGains
23463 USD
us-gaap Available For Sale Securities Gross Unrealized Loss
AvailableForSaleSecuritiesGrossUnrealizedLoss
16849 USD
CY2015Q2 us-gaap Available For Sale Securities
AvailableForSaleSecurities
2180982 USD
us-gaap Incremental Common Shares Attributable To Conversion Of Preferred Stock
IncrementalCommonSharesAttributableToConversionOfPreferredStock
1208723 shares
CY2014Q2 us-gaap Incremental Common Shares Attributable To Conversion Of Preferred Stock
IncrementalCommonSharesAttributableToConversionOfPreferredStock
1217457 shares
CY2015Q2 us-gaap Incremental Common Shares Attributable To Conversion Of Preferred Stock
IncrementalCommonSharesAttributableToConversionOfPreferredStock
1321537 shares
CY2014Q4 issm Stock Issuance Date
StockIssuanceDate
2015-01-08
CY2015Q1 issm Stock Issuance Date
StockIssuanceDate
2015-04-13
CY2015Q2 issm Stock Issuance Date
StockIssuanceDate
2015-07-10
CY2015Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
12500 USD

Files In Submission

Name View Source Status
0001144204-15-049241-index-headers.html Edgar Link pending
0001144204-15-049241-index.html Edgar Link pending
0001144204-15-049241.txt Edgar Link pending
0001144204-15-049241-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
issm-20150630.xml Edgar Link completed
issm-20150630.xsd Edgar Link pending
issm-20150630_cal.xml Edgar Link unprocessable
issm-20150630_def.xml Edgar Link unprocessable
issm-20150630_lab.xml Edgar Link unprocessable
issm-20150630_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
v417197_10q.htm Edgar Link pending
v417197_ex31-1.htm Edgar Link pending
v417197_ex31-2.htm Edgar Link pending
v417197_ex32-1.htm Edgar Link pending
v417197_ex32-2.htm Edgar Link pending